Evidence of Fraudulent Claims by Hologic/Gen-Probe in relation to Daniel Densham’s IP Portfolio. PacBio Deal rears its head.

Evidence of Fraudulent Claims by Hologic/Gen-Probe in relation to Daniel Densham’s IP Portfolio brings Pacbio Deal into focus.

The fraudulently claimed IP portfolio of Daniel Densham, Managing Director of Molecular Research Limited, appears have been Licensed to Pacific Biosciences Inc, within the questionable Pacific (gen probe)/Hologic deal. Read More